ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pre-Implantation Genetic Diagnosis (PGD) Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-33Q5648
Home | Market Reports | Health| Reproductive Health
Global Pre Implantation Genetic Diagnosis PGD Market Insights Forecast to 2028
BUY CHAPTERS

Global Pre-Implantation Genetic Diagnosis (PGD) Market Insights, Forecast to 2030

Code: QYRE-Auto-33Q5648
Report
December 2024
Pages:109
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Roche
Genea Limited
Quest Diagnostics
Illumina Inc
Natera
Cooper Medical, Inc.
LabCorp
California Pacific Medical Center (CPMC)
Thermo Fisher Scientific Inc
IGENOMIX
Reproductive Genetic Innovations
CombiMatrix

Pre-Implantation Genetic Diagnosis (PGD) Market Size

The global Pre-Implantation Genetic Diagnosis (PGD) market is projected to grow from US$ 106.6 million in 2024 to US$ 137.1 million by 2030, at a Compound Annual Growth Rate (CAGR) of 4.3% during the forecast period.

Pre-Implantation Genetic Diagnosis (PGD) Market

Pre-Implantation Genetic Diagnosis (PGD) Market

Pre-Implantation Genetic Diagnosis (PGD) is the genetic profiling of embryos prior to implantation (as a form of embryo profiling), and sometimes even of oocytes prior to fertilization.
Market Analysis and Insights: Global Pre-Implantation Genetic Diagnosis (PGD) Market
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Pre-Implantation Genetic Diagnosis (PGD) market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Pre-Implantation Genetic Diagnosis (PGD), also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Pre-Implantation Genetic Diagnosis (PGD), and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Pre-Implantation Genetic Diagnosis (PGD) revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Pre-Implantation Genetic Diagnosis (PGD) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Pre-Implantation Genetic Diagnosis (PGD) revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Pre-Implantation Genetic Diagnosis (PGD) Market Report

Report Metric Details
Report Name Pre-Implantation Genetic Diagnosis (PGD) Market
Accounted market size in 2024 US$ 106.6 million
Forecasted market size in 2030 US$ 137.1 million
CAGR 4.3
Base Year 2024
Forecasted years 2025 - 2030
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Roche, Genea Limited, Quest Diagnostics, Illumina, Inc., Natera, Inc., Cooper Medical, Inc., LabCorp, California Pacific Medical Center (CPMC), Thermo Fisher Scientific Inc., IGENOMIX, Reproductive Genetic Innovations, CombiMatrix
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Pre-Implantation Genetic Diagnosis (PGD) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Pre-Implantation Genetic Diagnosis (PGD) companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pre-Implantation Genetic Diagnosis (PGD) revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

How fast is Pre-Implantation Genetic Diagnosis (PGD) Market growing?

Ans: The Pre-Implantation Genetic Diagnosis (PGD) Market witnessing a CAGR of 4.3 during the forecast period 2025-2030.

What is the Pre-Implantation Genetic Diagnosis (PGD) Market size in 2030?

Ans: The Pre-Implantation Genetic Diagnosis (PGD) Market size in 2030 will be US$ 137.1 million.

Who are the main players in the Pre-Implantation Genetic Diagnosis (PGD) Market report?

Ans: The main players in the Pre-Implantation Genetic Diagnosis (PGD) Market are Roche, Genea Limited, Quest Diagnostics, Illumina, Inc., Natera, Inc., Cooper Medical, Inc., LabCorp, California Pacific Medical Center (CPMC), Thermo Fisher Scientific Inc., IGENOMIX, Reproductive Genetic Innovations, CombiMatrix

What are the Application segmentation covered in the Pre-Implantation Genetic Diagnosis (PGD) Market report?

Ans: The Applications covered in the Pre-Implantation Genetic Diagnosis (PGD) Market report are Stem Cell Therapy, IVF Prognosis, Late-Onset Genetic Disorders, Inherited Genetic Disease, Others

What are the Type segmentation covered in the Pre-Implantation Genetic Diagnosis (PGD) Market report?

Ans: The Types covered in the Pre-Implantation Genetic Diagnosis (PGD) Market report are Chromosomal Abnormalities, X-linked Diseases, Freeze Embryo Testing, Aneuploidy Screening, HLA, Others

Recommended Reports

Genetic Testing Markets

Reproductive Health

Molecular Diagnostics

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Chromosomal Abnormalities
1.2.3 X-linked Diseases
1.2.4 Freeze Embryo Testing
1.2.5 Aneuploidy Screening
1.2.6 HLA
1.2.7 Others
1.3 Market by Application
1.3.1 Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Stem Cell Therapy
1.3.3 IVF Prognosis
1.3.4 Late-Onset Genetic Disorders
1.3.5 Inherited Genetic Disease
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pre-Implantation Genetic Diagnosis (PGD) Market Perspective (2019-2030)
2.2 Global Pre-Implantation Genetic Diagnosis (PGD) Growth Trends by Region
2.2.1 Pre-Implantation Genetic Diagnosis (PGD) Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Pre-Implantation Genetic Diagnosis (PGD) Historic Market Size by Region (2019-2024)
2.2.3 Pre-Implantation Genetic Diagnosis (PGD) Forecasted Market Size by Region (2025-2030)
2.3 Pre-Implantation Genetic Diagnosis (PGD) Market Dynamics
2.3.1 Pre-Implantation Genetic Diagnosis (PGD) Industry Trends
2.3.2 Pre-Implantation Genetic Diagnosis (PGD) Market Drivers
2.3.3 Pre-Implantation Genetic Diagnosis (PGD) Market Challenges
2.3.4 Pre-Implantation Genetic Diagnosis (PGD) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Pre-Implantation Genetic Diagnosis (PGD) by Players
3.1.1 Global Pre-Implantation Genetic Diagnosis (PGD) Revenue by Players (2019-2024)
3.1.2 Global Pre-Implantation Genetic Diagnosis (PGD) Revenue Market Share by Players (2019-2024)
3.2 Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Pre-Implantation Genetic Diagnosis (PGD), Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Pre-Implantation Genetic Diagnosis (PGD) Market Concentration Ratio
3.4.1 Global Pre-Implantation Genetic Diagnosis (PGD) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pre-Implantation Genetic Diagnosis (PGD) Revenue in 2023
3.5 Global Key Players of Pre-Implantation Genetic Diagnosis (PGD) Head office and Area Served
3.6 Global Key Players of Pre-Implantation Genetic Diagnosis (PGD), Product and Application
3.7 Global Key Players of Pre-Implantation Genetic Diagnosis (PGD), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Pre-Implantation Genetic Diagnosis (PGD) Breakdown Data by Type
4.1 Global Pre-Implantation Genetic Diagnosis (PGD) Historic Market Size by Type (2019-2024)
4.2 Global Pre-Implantation Genetic Diagnosis (PGD) Forecasted Market Size by Type (2025-2030)
5 Pre-Implantation Genetic Diagnosis (PGD) Breakdown Data by Application
5.1 Global Pre-Implantation Genetic Diagnosis (PGD) Historic Market Size by Application (2019-2024)
5.2 Global Pre-Implantation Genetic Diagnosis (PGD) Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Pre-Implantation Genetic Diagnosis (PGD) Market Size (2019-2030)
6.2 North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type
6.2.1 North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2019-2024)
6.2.2 North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2025-2030)
6.2.3 North America Pre-Implantation Genetic Diagnosis (PGD) Market Share by Type (2019-2030)
6.3 North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application
6.3.1 North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2019-2024)
6.3.2 North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2025-2030)
6.3.3 North America Pre-Implantation Genetic Diagnosis (PGD) Market Share by Application (2019-2030)
6.4 North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country
6.4.1 North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2019-2024)
6.4.3 North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size (2019-2030)
7.2 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type
7.2.1 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2019-2024)
7.2.2 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2025-2030)
7.2.3 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Share by Type (2019-2030)
7.3 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application
7.3.1 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2019-2024)
7.3.2 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2025-2030)
7.3.3 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Share by Application (2019-2030)
7.4 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country
7.4.1 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2019-2024)
7.4.3 Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Pre-Implantation Genetic Diagnosis (PGD) Market Size (2019-2030)
8.2 China Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type
8.2.1 China Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2019-2024)
8.2.2 China Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2025-2030)
8.2.3 China Pre-Implantation Genetic Diagnosis (PGD) Market Share by Type (2019-2030)
8.3 China Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application
8.3.1 China Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2019-2024)
8.3.2 China Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2025-2030)
8.3.3 China Pre-Implantation Genetic Diagnosis (PGD) Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Pre-Implantation Genetic Diagnosis (PGD) Market Size (2019-2030)
9.2 Asia Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type
9.2.1 Asia Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2019-2024)
9.2.2 Asia Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2025-2030)
9.2.3 Asia Pre-Implantation Genetic Diagnosis (PGD) Market Share by Type (2019-2030)
9.3 Asia Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application
9.3.1 Asia Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2019-2024)
9.3.2 Asia Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2025-2030)
9.3.3 Asia Pre-Implantation Genetic Diagnosis (PGD) Market Share by Application (2019-2030)
9.4 Asia Pre-Implantation Genetic Diagnosis (PGD) Market Size by Region
9.4.1 Asia Pre-Implantation Genetic Diagnosis (PGD) Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Pre-Implantation Genetic Diagnosis (PGD) Market Size by Region (2019-2024)
9.4.3 Asia Pre-Implantation Genetic Diagnosis (PGD) Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type
10.2.1 Middle East, Africa, and Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application
10.3.1 Middle East, Africa, and Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country
10.4.1 Middle East, Africa, and Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Pre-Implantation Genetic Diagnosis (PGD) Introduction
11.1.4 Roche Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2019-2024)
11.1.5 Roche Recent Developments
11.2 Genea Limited
11.2.1 Genea Limited Company Details
11.2.2 Genea Limited Business Overview
11.2.3 Genea Limited Pre-Implantation Genetic Diagnosis (PGD) Introduction
11.2.4 Genea Limited Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2019-2024)
11.2.5 Genea Limited Recent Developments
11.3 Quest Diagnostics
11.3.1 Quest Diagnostics Company Details
11.3.2 Quest Diagnostics Business Overview
11.3.3 Quest Diagnostics Pre-Implantation Genetic Diagnosis (PGD) Introduction
11.3.4 Quest Diagnostics Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2019-2024)
11.3.5 Quest Diagnostics Recent Developments
11.4 Illumina, Inc.
11.4.1 Illumina, Inc. Company Details
11.4.2 Illumina, Inc. Business Overview
11.4.3 Illumina, Inc. Pre-Implantation Genetic Diagnosis (PGD) Introduction
11.4.4 Illumina, Inc. Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2019-2024)
11.4.5 Illumina, Inc. Recent Developments
11.5 Natera, Inc.
11.5.1 Natera, Inc. Company Details
11.5.2 Natera, Inc. Business Overview
11.5.3 Natera, Inc. Pre-Implantation Genetic Diagnosis (PGD) Introduction
11.5.4 Natera, Inc. Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2019-2024)
11.5.5 Natera, Inc. Recent Developments
11.6 Cooper Medical, Inc.
11.6.1 Cooper Medical, Inc. Company Details
11.6.2 Cooper Medical, Inc. Business Overview
11.6.3 Cooper Medical, Inc. Pre-Implantation Genetic Diagnosis (PGD) Introduction
11.6.4 Cooper Medical, Inc. Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2019-2024)
11.6.5 Cooper Medical, Inc. Recent Developments
11.7 LabCorp
11.7.1 LabCorp Company Details
11.7.2 LabCorp Business Overview
11.7.3 LabCorp Pre-Implantation Genetic Diagnosis (PGD) Introduction
11.7.4 LabCorp Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2019-2024)
11.7.5 LabCorp Recent Developments
11.8 California Pacific Medical Center (CPMC)
11.8.1 California Pacific Medical Center (CPMC) Company Details
11.8.2 California Pacific Medical Center (CPMC) Business Overview
11.8.3 California Pacific Medical Center (CPMC) Pre-Implantation Genetic Diagnosis (PGD) Introduction
11.8.4 California Pacific Medical Center (CPMC) Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2019-2024)
11.8.5 California Pacific Medical Center (CPMC) Recent Developments
11.9 Thermo Fisher Scientific Inc.
11.9.1 Thermo Fisher Scientific Inc. Company Details
11.9.2 Thermo Fisher Scientific Inc. Business Overview
11.9.3 Thermo Fisher Scientific Inc. Pre-Implantation Genetic Diagnosis (PGD) Introduction
11.9.4 Thermo Fisher Scientific Inc. Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2019-2024)
11.9.5 Thermo Fisher Scientific Inc. Recent Developments
11.10 IGENOMIX
11.10.1 IGENOMIX Company Details
11.10.2 IGENOMIX Business Overview
11.10.3 IGENOMIX Pre-Implantation Genetic Diagnosis (PGD) Introduction
11.10.4 IGENOMIX Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2019-2024)
11.10.5 IGENOMIX Recent Developments
11.11 Reproductive Genetic Innovations
11.11.1 Reproductive Genetic Innovations Company Details
11.11.2 Reproductive Genetic Innovations Business Overview
11.11.3 Reproductive Genetic Innovations Pre-Implantation Genetic Diagnosis (PGD) Introduction
11.11.4 Reproductive Genetic Innovations Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2019-2024)
11.11.5 Reproductive Genetic Innovations Recent Developments
11.12 CombiMatrix
11.12.1 CombiMatrix Company Details
11.12.2 CombiMatrix Business Overview
11.12.3 CombiMatrix Pre-Implantation Genetic Diagnosis (PGD) Introduction
11.12.4 CombiMatrix Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2019-2024)
11.12.5 CombiMatrix Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Roche
Genea Limited
Quest Diagnostics
Illumina Inc
Natera
Cooper Medical, Inc.
LabCorp
California Pacific Medical Center (CPMC)
Thermo Fisher Scientific Inc
IGENOMIX
Reproductive Genetic Innovations
CombiMatrix
List of Tables
    Table 1. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Chromosomal Abnormalities
    Table 3. Key Players of X-linked Diseases
    Table 4. Key Players of Freeze Embryo Testing
    Table 5. Key Players of Aneuploidy Screening
    Table 6. Key Players of HLA
    Table 7. Key Players of Others
    Table 8. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 9. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 10. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size by Region (2019-2024) & (US$ Million)
    Table 11. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Region (2019-2024)
    Table 12. Global Pre-Implantation Genetic Diagnosis (PGD) Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 13. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Region (2025-2030)
    Table 14. Pre-Implantation Genetic Diagnosis (PGD) Market Trends
    Table 15. Pre-Implantation Genetic Diagnosis (PGD) Market Drivers
    Table 16. Pre-Implantation Genetic Diagnosis (PGD) Market Challenges
    Table 17. Pre-Implantation Genetic Diagnosis (PGD) Market Restraints
    Table 18. Global Pre-Implantation Genetic Diagnosis (PGD) Revenue by Players (2019-2024) & (US$ Million)
    Table 19. Global Pre-Implantation Genetic Diagnosis (PGD) Revenue Share by Players (2019-2024)
    Table 20. Global Top Pre-Implantation Genetic Diagnosis (PGD) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pre-Implantation Genetic Diagnosis (PGD) as of 2023)
    Table 21. Global Pre-Implantation Genetic Diagnosis (PGD) Industry Ranking 2022 VS 2023 VS 2024
    Table 22. Global 5 Largest Players Market Share by Pre-Implantation Genetic Diagnosis (PGD) Revenue (CR5 and HHI) & (2019-2024)
    Table 23. Global Key Players of Pre-Implantation Genetic Diagnosis (PGD), Headquarters and Area Served
    Table 24. Global Key Players of Pre-Implantation Genetic Diagnosis (PGD), Product and Application
    Table 25. Global Key Players of Pre-Implantation Genetic Diagnosis (PGD), Product and Application
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2019-2024) & (US$ Million)
    Table 28. Global Pre-Implantation Genetic Diagnosis (PGD) Revenue Market Share by Type (2019-2024)
    Table 29. Global Pre-Implantation Genetic Diagnosis (PGD) Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 30. Global Pre-Implantation Genetic Diagnosis (PGD) Revenue Market Share by Type (2025-2030)
    Table 31. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2019-2024) & (US$ Million)
    Table 32. Global Pre-Implantation Genetic Diagnosis (PGD) Revenue Share by Application (2019-2024)
    Table 33. Global Pre-Implantation Genetic Diagnosis (PGD) Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 34. Global Pre-Implantation Genetic Diagnosis (PGD) Revenue Share by Application (2025-2030)
    Table 35. North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2019-2024) & (US$ Million)
    Table 36. North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2025-2030) & (US$ Million)
    Table 37. North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2019-2024) & (US$ Million)
    Table 38. North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2025-2030) & (US$ Million)
    Table 39. North America Pre-Implantation Genetic Diagnosis (PGD) Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 40. North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2019-2024) & (US$ Million)
    Table 41. North America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2025-2030) & (US$ Million)
    Table 42. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2019-2024) & (US$ Million)
    Table 43. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2025-2030) & (US$ Million)
    Table 44. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2019-2024) & (US$ Million)
    Table 45. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2025-2030) & (US$ Million)
    Table 46. Europe Pre-Implantation Genetic Diagnosis (PGD) Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 47. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2019-2024) & (US$ Million)
    Table 48. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2025-2030) & (US$ Million)
    Table 49. China Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2019-2024) & (US$ Million)
    Table 50. China Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2025-2030) & (US$ Million)
    Table 51. China Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2019-2024) & (US$ Million)
    Table 52. China Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2025-2030) & (US$ Million)
    Table 53. Asia Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2019-2024) & (US$ Million)
    Table 54. Asia Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2025-2030) & (US$ Million)
    Table 55. Asia Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2019-2024) & (US$ Million)
    Table 56. Asia Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2025-2030) & (US$ Million)
    Table 57. Asia Pre-Implantation Genetic Diagnosis (PGD) Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 58. Asia Pre-Implantation Genetic Diagnosis (PGD) Market Size by Region (2019-2024) & (US$ Million)
    Table 59. Asia Pre-Implantation Genetic Diagnosis (PGD) Market Size by Region (2025-2030) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2019-2024) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Type (2025-2030) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2019-2024) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Application (2025-2030) & (US$ Million)
    Table 64. Middle East, Africa, and Latin America Pre-Implantation Genetic Diagnosis (PGD) Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 65. Middle East, Africa, and Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2019-2024) & (US$ Million)
    Table 66. Middle East, Africa, and Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size by Country (2025-2030) & (US$ Million)
    Table 67. Roche Company Details
    Table 68. Roche Business Overview
    Table 69. Roche Pre-Implantation Genetic Diagnosis (PGD) Product
    Table 70. Roche Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2019-2024) & (US$ Million)
    Table 71. Roche Recent Developments
    Table 72. Genea Limited Company Details
    Table 73. Genea Limited Business Overview
    Table 74. Genea Limited Pre-Implantation Genetic Diagnosis (PGD) Product
    Table 75. Genea Limited Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2019-2024) & (US$ Million)
    Table 76. Genea Limited Recent Developments
    Table 77. Quest Diagnostics Company Details
    Table 78. Quest Diagnostics Business Overview
    Table 79. Quest Diagnostics Pre-Implantation Genetic Diagnosis (PGD) Product
    Table 80. Quest Diagnostics Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2019-2024) & (US$ Million)
    Table 81. Quest Diagnostics Recent Developments
    Table 82. Illumina, Inc. Company Details
    Table 83. Illumina, Inc. Business Overview
    Table 84. Illumina, Inc. Pre-Implantation Genetic Diagnosis (PGD) Product
    Table 85. Illumina, Inc. Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2019-2024) & (US$ Million)
    Table 86. Illumina, Inc. Recent Developments
    Table 87. Natera, Inc. Company Details
    Table 88. Natera, Inc. Business Overview
    Table 89. Natera, Inc. Pre-Implantation Genetic Diagnosis (PGD) Product
    Table 90. Natera, Inc. Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2019-2024) & (US$ Million)
    Table 91. Natera, Inc. Recent Developments
    Table 92. Cooper Medical, Inc. Company Details
    Table 93. Cooper Medical, Inc. Business Overview
    Table 94. Cooper Medical, Inc. Pre-Implantation Genetic Diagnosis (PGD) Product
    Table 95. Cooper Medical, Inc. Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2019-2024) & (US$ Million)
    Table 96. Cooper Medical, Inc. Recent Developments
    Table 97. LabCorp Company Details
    Table 98. LabCorp Business Overview
    Table 99. LabCorp Pre-Implantation Genetic Diagnosis (PGD) Product
    Table 100. LabCorp Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2019-2024) & (US$ Million)
    Table 101. LabCorp Recent Developments
    Table 102. California Pacific Medical Center (CPMC) Company Details
    Table 103. California Pacific Medical Center (CPMC) Business Overview
    Table 104. California Pacific Medical Center (CPMC) Pre-Implantation Genetic Diagnosis (PGD) Product
    Table 105. California Pacific Medical Center (CPMC) Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2019-2024) & (US$ Million)
    Table 106. California Pacific Medical Center (CPMC) Recent Developments
    Table 107. Thermo Fisher Scientific Inc. Company Details
    Table 108. Thermo Fisher Scientific Inc. Business Overview
    Table 109. Thermo Fisher Scientific Inc. Pre-Implantation Genetic Diagnosis (PGD) Product
    Table 110. Thermo Fisher Scientific Inc. Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2019-2024) & (US$ Million)
    Table 111. Thermo Fisher Scientific Inc. Recent Developments
    Table 112. IGENOMIX Company Details
    Table 113. IGENOMIX Business Overview
    Table 114. IGENOMIX Pre-Implantation Genetic Diagnosis (PGD) Product
    Table 115. IGENOMIX Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2019-2024) & (US$ Million)
    Table 116. IGENOMIX Recent Developments
    Table 117. Reproductive Genetic Innovations Company Details
    Table 118. Reproductive Genetic Innovations Business Overview
    Table 119. Reproductive Genetic Innovations Pre-Implantation Genetic Diagnosis (PGD) Product
    Table 120. Reproductive Genetic Innovations Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2019-2024) & (US$ Million)
    Table 121. Reproductive Genetic Innovations Recent Developments
    Table 122. CombiMatrix Company Details
    Table 123. CombiMatrix Business Overview
    Table 124. CombiMatrix Pre-Implantation Genetic Diagnosis (PGD) Product
    Table 125. CombiMatrix Revenue in Pre-Implantation Genetic Diagnosis (PGD) Business (2019-2024) & (US$ Million)
    Table 126. CombiMatrix Recent Developments
    Table 127. Research Programs/Design for This Report
    Table 128. Key Data Information from Secondary Sources
    Table 129. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Type: 2023 VS 2030
    Figure 3. Chromosomal Abnormalities Features
    Figure 4. X-linked Diseases Features
    Figure 5. Freeze Embryo Testing Features
    Figure 6. Aneuploidy Screening Features
    Figure 7. HLA Features
    Figure 8. Others Features
    Figure 9. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 10. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Application: 2023 VS 2030
    Figure 11. Stem Cell Therapy Case Studies
    Figure 12. IVF Prognosis Case Studies
    Figure 13. Late-Onset Genetic Disorders Case Studies
    Figure 14. Inherited Genetic Disease Case Studies
    Figure 15. Others Case Studies
    Figure 16. Pre-Implantation Genetic Diagnosis (PGD) Report Years Considered
    Figure 17. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 18. Global Pre-Implantation Genetic Diagnosis (PGD) Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 19. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Region: 2023 VS 2030
    Figure 20. Global Pre-Implantation Genetic Diagnosis (PGD) Market Share by Players in 2023
    Figure 21. Global Top Pre-Implantation Genetic Diagnosis (PGD) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pre-Implantation Genetic Diagnosis (PGD) as of 2023)
    Figure 22. The Top 10 and 5 Players Market Share by Pre-Implantation Genetic Diagnosis (PGD) Revenue in 2023
    Figure 23. North America Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. North America Pre-Implantation Genetic Diagnosis (PGD) Market Share by Type (2019-2030)
    Figure 25. North America Pre-Implantation Genetic Diagnosis (PGD) Market Share by Application (2019-2030)
    Figure 26. North America Pre-Implantation Genetic Diagnosis (PGD) Market Share by Country (2019-2030)
    Figure 27. United States Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. Canada Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY (2019-2030) & (US$ Million)
    Figure 30. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Share by Type (2019-2030)
    Figure 31. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Share by Application (2019-2030)
    Figure 32. Europe Pre-Implantation Genetic Diagnosis (PGD) Market Share by Country (2019-2030)
    Figure 33. Germany Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. France Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. U.K. Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. Italy Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Russia Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. Nordic Countries Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. China Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY (2019-2030) & (US$ Million)
    Figure 40. China Pre-Implantation Genetic Diagnosis (PGD) Market Share by Type (2019-2030)
    Figure 41. China Pre-Implantation Genetic Diagnosis (PGD) Market Share by Application (2019-2030)
    Figure 42. Asia Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY (2019-2030) & (US$ Million)
    Figure 43. Asia Pre-Implantation Genetic Diagnosis (PGD) Market Share by Type (2019-2030)
    Figure 44. Asia Pre-Implantation Genetic Diagnosis (PGD) Market Share by Application (2019-2030)
    Figure 45. Asia Pre-Implantation Genetic Diagnosis (PGD) Market Share by Region (2019-2030)
    Figure 46. Japan Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. South Korea Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. China Taiwan Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 49. Southeast Asia Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 50. India Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 51. Australia Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 52. Middle East, Africa, and Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY (2019-2030) & (US$ Million)
    Figure 53. Middle East, Africa, and Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Share by Type (2019-2030)
    Figure 54. Middle East, Africa, and Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Share by Application (2019-2030)
    Figure 55. Middle East, Africa, and Latin America Pre-Implantation Genetic Diagnosis (PGD) Market Share by Country (2019-2030)
    Figure 56. Brazil Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Mexico Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. Turkey Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 59. Saudi Arabia Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 60. Israel Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 61. GCC Countries Pre-Implantation Genetic Diagnosis (PGD) Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 62. Roche Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2019-2024)
    Figure 63. Genea Limited Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2019-2024)
    Figure 64. Quest Diagnostics Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2019-2024)
    Figure 65. Illumina, Inc. Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2019-2024)
    Figure 66. Natera, Inc. Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2019-2024)
    Figure 67. Cooper Medical, Inc. Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2019-2024)
    Figure 68. LabCorp Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2019-2024)
    Figure 69. California Pacific Medical Center (CPMC) Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2019-2024)
    Figure 70. Thermo Fisher Scientific Inc. Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2019-2024)
    Figure 71. IGENOMIX Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2019-2024)
    Figure 72. Reproductive Genetic Innovations Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2019-2024)
    Figure 73. CombiMatrix Revenue Growth Rate in Pre-Implantation Genetic Diagnosis (PGD) Business (2019-2024)
    Figure 74. Bottom-up and Top-down Approaches for This Report
    Figure 75. Data Triangulation
    Figure 76. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Global Preimplantation Genetic Diagnosis Market Insights Forecast to 2030
Global Preimplantation Genetic Diagnostics PGD Market Research Report 2024
Preimplantation genetic testing market
Preimplantation Genetic Diagnosis PGD Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Preimplantation Genetic Screening PGS Technology Market Research Report 2024
Global Non invasive Preimplantation Genetic Testing Market Research Report 2024
Global Pre Pregnancy Genetic Testing Market Research Report 2024
Global Preimplantation Genetic Screening Market Research Report 2025
Global Embryo Biopsy Medium Market Research Report 2025
Ovulation Disorder Diagnosis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Genetic Counseling Market Research Report 2024
Global Newborn and Prenatal Genetic Testing Market Insights Forecast to 2030
Global Preimplantation Genetic Testing for Aneuploidy Kits Market Research Report 2025
Global Genetic Disease Diagnostic Market Research Report 2025
Global Preimplantation Genetic Testing for Monogenic Single Gene Defects Kits Market Research Report 2025
Global Reproductive Genetics Reagents Market Research Report 2024
Global Prenatal Genetic Screening Test Market Research Report 2024
In Vitro Fertilization IVF Treatment Market
Pre marital and Pre Pregnancy Genetic Testing Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Neonatal Genetic Disease Diagnosis Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions